Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 09, 2023

SELL
$8.36 - $11.37 $30,806 - $41,898
-3,685 Reduced 8.59%
39,233 $347,000
Q4 2022

Feb 10, 2023

BUY
$7.95 - $9.48 $341,198 - $406,862
42,918 New
42,918 $391,000
Q2 2021

Aug 12, 2021

SELL
$9.9 - $11.56 $3.42 Million - $3.99 Million
-345,263 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$10.34 - $12.81 $29.3 Million - $36.3 Million
-2,835,932 Reduced 89.15%
345,263 $3.98 Million
Q4 2020

Feb 16, 2021

SELL
$8.61 - $11.04 $1.57 Million - $2.02 Million
-182,881 Reduced 5.44%
3,181,195 $30.7 Million
Q3 2020

Nov 12, 2020

BUY
$8.57 - $12.69 $15.1 Million - $22.3 Million
1,759,561 Added 109.66%
3,364,076 $30.3 Million
Q2 2020

Aug 13, 2020

BUY
$8.12 - $13.12 $8.83 Million - $14.3 Million
1,087,898 Added 210.58%
1,604,515 $19.8 Million
Q1 2020

May 13, 2020

BUY
$6.69 - $13.45 $3.46 Million - $6.95 Million
516,617 New
516,617 $4.64 Million
Q2 2019

Aug 07, 2019

SELL
$8.12 - $15.72 $6.81 Million - $13.2 Million
-838,120 Closed
0 $0
Q1 2019

May 08, 2019

SELL
$15.58 - $20.01 $21.4 Million - $27.5 Million
-1,373,412 Reduced 62.1%
838,120 $13.1 Million
Q4 2018

Feb 12, 2019

BUY
$14.59 - $23.84 $3.38 Million - $5.51 Million
231,332 Added 11.68%
2,211,532 $34.1 Million
Q3 2018

Nov 13, 2018

BUY
$21.06 - $25.65 $1.53 Million - $1.87 Million
72,875 Added 3.82%
1,980,200 $42.7 Million
Q2 2018

Aug 02, 2018

SELL
$16.77 - $24.71 $141,287 - $208,181
-8,425 Reduced 0.44%
1,907,325 $46.4 Million
Q1 2018

May 14, 2018

BUY
$16.68 - $22.07 $32 Million - $42.3 Million
1,915,750 New
1,915,750 $32.7 Million

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19.8B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Connor, Clark & Lunn Investment Management Ltd. Portfolio

Follow Connor, Clark & Lunn Investment Management Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Connor, Clark & Lunn Investment Management Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Connor, Clark & Lunn Investment Management Ltd. with notifications on news.